Maximilian Diehn

Maximilian Diehn is an American radiation oncologist and cancer biologist. He is a Professor and Division Chief of Radiation and Cancer Biology in the Department of Radiation Oncology, and Vice Chair of Research in the Department of Radiation Oncology at the Stanford University School of Medicine. Diehn also co-leads the Cancer Biology Program at the Stanford Cancer Institute and holds the Jack, Lulu, and Sam Willson Professorship.

Education Diehn received his Bachelor of Science degree in Biochemical Sciences from Harvard University. He earned both his MD and PhD in Biophysics from Stanford University. His laboratory has developed techniques for detecting and analyzing ctDNA, which can be used for early cancer detection, monitoring treatment response, and identifying minimal residual disease (MRD) after therapy. This work has been particularly influential in the context of lung cancer and other solid tumors.

In 2021, Diehn co-founded Foresight Diagnostics, a company focused on developing ctDNA-based tests for cancer detection and monitoring, based on technology developed in his lab.

Honors and awards

Member of the National Academy of Medicine (2021) Member of the American Society for Clinical Investigation NIH Director's New Innovator Award (2013) V Foundation Scholar Award Doris Duke Clinical Scientist Development Award

Sources: